- Lobbying
- Lobbying by Tiber Creek Group (on behalf of Merck & Co., Inc)
Lobbying Relationship
Bills mentioned
S.1317: Medicaid and CHIP Quality Improvement Act of 2017
Sponsor: Sherrod Brown (D-Ohio)
S.934: FDA Reauthorization Act of 2017
Sponsor: Lamar Alexander (R-Tenn.)
S.469: Affordable and Safe Prescription Drug Importation Act
Sponsor: Bernard Sanders (ID-Vt.)
H.R.2029: Consolidated Appropriations Act, 2016
Sponsor: Charlie Dent (R-Pa.)
H.R.1625: Consolidated Appropriations Act, 2018
Sponsor: Edward Royce (R-Calif.)
H.R.1865: Further Consolidated Appropriations Act, 2020
Sponsor: Bill Pascrell Jr. (D-N.J.)
H.R.6201: Families First Coronavirus Response Act
Sponsor: Nita M. Lowey (D-N.Y.)
S.3548: CARES Act
Sponsor: Mitch McConnell (R-Ky.)
H.R.6800: The Heroes Act
Sponsor: Nita M. Lowey (D-N.Y.)
H.R.133: Consolidated Appropriations Act, 2021
Sponsor: Henry Cuellar (D-Texas)
H.R.133: David’s Law
Sponsor: Sheila Jackson Lee (D-Texas)
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Bryant Hall | Legislative Correspondent, Senator Bob Graham Legislative Assistant, Senator Bob Graham Health Care Counsel, Senator Bob Graham Legislative Director, Senator Bob Graham Staff Director, Senate Comm. on Veterans Affairs |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Medicare
Pharmacy
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate